What is Avid Bioservices?
Founded in 1981 and headquartered in California, Avid Bioservices is a specialized contract development and manufacturing organization (CDMO) focused on the production of biopharmaceutical drug substances. The company leverages mammalian cell culture technology to support the development and commercialization of complex biologics, positioning itself as a key partner for biotechnology and pharmaceutical firms seeking expertise in biomanufacturing.
How much funding has Avid Bioservices raised?
Avid Bioservices has raised a total of $1.5M across 1 funding round:
Debt
$1.5M
Debt (2003): $1.5M, investors not publicly disclosed
What's next for Avid Bioservices?
The substantial enterprise-level funding and recent strategic investment indicate a strong trajectory for Avid Bioservices. This capital is likely to fuel further expansion of its manufacturing capabilities, investment in advanced technologies, and potentially broaden its service offerings to meet the growing demand for complex biopharmaceutical production. The company is poised to enhance its role in bringing critical therapies to market, supported by this significant financial backing.
See full Avid Bioservices company page
